References
- Alam A, Shaikh S, Ahmad SS, Ansari MA, Shakil S, Rizvi SMD, Shakil S, Imran M, Haneef M, Abuzenadah AM, Kamal MA. Molecular interaction of human brain acetylcholinesterase with a natural inhibitor Huperzine-B: An Enzoinformatics approach. CNS & Neurological Disorders - Drug Targets 2014; 13: 487–490
- Aniszewski T. 2007. Alkaloids - Secrets of Life. Elsevier. ISBN: 978-0-444-52736-3.
- Burnell RH, Mootoo BS. Lycopodium alkaloids: Part IV. Alkaloids of Jamaican lycopodium Clavatum linn. Can J Chem 1961; 39: 1090–1093
- Burnell RHJ. Extraction of alkaloids from Lycopodium, fawcetti, Lloyd and Underwood. Chem Soc 1959; 41: 3091
- Darreh-Shori T, Soininen H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: A review of recent clinical studies. Curr Alzheimer Res 2010; 7: 67–73
- Heathcock CH, Blumenkopf TA, Smith KM. Total synthesis of (±) fawcettimine. J Org Chem 1989; 54: 1548–1562
- Hesse M. 2002. Alkaloids: Nature's Curse or Blessing? In. Wiley-VCH. 24–26
- Ishiuchi K, Kubota T, Hoshino T, Obara Y, Nakahata N, Kobayashi J. Lycopladines B-D and lyconadin B, new alkaloids from Lycopodium complanatum. Bioorg Med Chem 2006; 14: 5995–6000
- Kamal MA, Nasim FH, Al-Jafri AA. In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate. Mol Cell Biochem 1996; 159: 47–53
- Kobayashi J, Hirasawa Y, Yoshida N, Morita H. Complanadine A, a new dimeric alkaloid from Lycopodium complanatum. Tetrahedron Lett 2000; 41: 9069–9073
- Kobayashi J, Hirasawa Y, Yoshida N, Morita HJ. Lyconadin A, a novel alkaloid from Lycopodium complanatum. J Org Chem 2001; 66(17)5901–5904
- Morita H, Hirasawa Y, Shinzato T, Kobayashi J. New Phlegmarane-type, Cernuane-type, and Quinolizidine Alkaloids from Two Species of Lycopodium. Tetrahedron 2004; 60: 7015–7023
- Munoz-Delgado E, Montenegro MF, Campoy FJ, Moral-Naranjo MT, Cabezas-Herrera J, Kovacs G, Vidal CJ. Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types. FEBS J 2010; 277: 4519–4529
- Nunes B. The use of cholinesterases in ecotoxicology. Rev Environ Contam Toxicol 2011; 212: 29–59
- Shaikh S, Ahmad SS, Ansari MA, Shakil S, Rizvi1 SMD, Shakil S, Tabrez S, Akhtar S, Kamal MA. Prediction of comparative inhibition efficiency for a novel natural ligand, Galangin against human brain Acetylcholinesterase, butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics study. CNS & Neurological Disorders - Drug Targets 2014; 13: 452–459
- Shakil S, Khan AU. Interaction of 2009 CTX-M variants with drugs and inhibitors: A molecular modelling and docking study. J Proteomics Bioinformatics 2010; 3: 130–134
- Shakil S, Khan AU. Interaction of CTX-M-15 enzyme with cefotaxime: A molecular modelling and docking study. Bioinformation 2010; 4(10)468–472
- Silman I, Sussman JL. Acetylcholinesterase: ‘classical’ and ‘nonclassical’ functions and pharmacology. Curr Opin Pharmacol 2005; 5: 293–302
- Silman I, Sussman JL. Acetylcholinesterase: How is structure related to function?. Chem Biol Interact 2008; 175: 3–10
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science 1991; 253: 872–879
- Takayama H, Nishikawa Y, Kitajima M, Kogure N. A divergent approach for the total synthesis of Cernuane-type and Quinolizidine-type Lycopodium Alkaloids. Tetrahedron 2009; 65: 1608–1617
- Xu Y, Colletier JP, Weik M, Jiang H, Moult J, Silman I, Sussman JL. Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. Biophys J 2008; 95: 2500–2511